ARTICLE | Finance
Breathe in, cash out
How a new CEO and a big series A could take Genoa to value inflection
May 19, 2017 6:07 PM UTC
By installing a proven CEO and ponying up sufficient cash to clear Phase II development, Genoa Pharmaceuticals Inc.’s investors believe the company is primed to reach value inflection.
Genoa raised $62 million in a series A financing on May 15. The round was led by F-Prime Capital Partners and Edmond de Rothschild Investment Partners. Novo A/S, RiverVest Venture Partners and TPG Biotech also participated...
BCIQ Company Profiles